Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US6077846A · kind A · utility
8Cited by
25References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1996 |
| Grant date | Jun 20, 2000 |
| Priority date | — |
| Expiry date | Dec 17, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the treatment of conditions that can be treated with a nicotinic agonist by administering to a patient an effective amount of a 7-azabicyclo[2.2.1]-heptane or heptene. Specific conditions that may be treated include excess body weight, ulcerative colitis, aplthous ulcer, smoking, Parkinson's Disease, Alzeimer's Disease, and Tourette's Syndrome
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.